Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tango Therapeutics Q3 EPS $(0.23) Beats $(0.34) Estimate, Sales $10.73M Beat $7.32M Estimate

Author: Benzinga Newsdesk | November 08, 2023 08:15am
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.34) by 32.35 percent. This is a 30.3 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $10.73 million which beat the analyst consensus estimate of $7.32 million by 46.61 percent. This is a 55.09 percent increase over sales of $6.92 million the same period last year.

Posted In: TNGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist